The “nodule-in-nodule” architecture of hepatocellular carcinoma (HCC) is defined by the presence of one or more smaller inner nodules having different imaging features than a larger outer nodule (Fig. 1) [1]. This appearance is a variant of the “mosaic” architecture of HCC, that is defined as the presence of randomly distributed internal nodules or compartments, with different imaging features regarding enhancement, attenuation, intensity, and size [1, 2].
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.